BioCentury
ARTICLE | Company News

Otonomy gains on CMS coverage decision

May 21, 2016 12:39 AM UTC

Otonomy Inc. (NASDAQ:OTIC) gained $2.07 (18%) to $13.76 Friday after it said CMS assigned a C-code and approved transitional pass-through reimbursement for Otiprio ciprofloxacin otic suspension. The billing code becomes effective July 1, and Otonomy said it expects to retain pass-through status through YE18. ...